Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms.

Auteurs : Soumoy L, Wells M, Najem A, Krayem M, Ghanem G, Hambye S, Saussez S, Blankert B, Journe F
Jaar : 2020
Journal : Biology (Basel)
Volume : 9

Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells.

Auteurs : Absil L, Journe F, Larsimont D, Body JJ, Tafforeau L, Nonclercq D
Jaar : 2020
Journal : BMC Cancer
Volume : 20
Pagina's : 640

Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis.

Auteurs : Soumoy L, Schepkens C, Krayem M, Najem A, Tagliatti V, Ghanem G, Saussez S, Colet JM, Journe F
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12

HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas.

Auteurs : Lechien JR, Descamps G, Seminerio I, Furgiuele S, Dequanter D, Mouawad F, Badoual C, Journe F, Saussez S
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance.

Auteurs : Krayem M, Aftimos P, Najem A, van den Hooven T, van den Berg A, Hovestad-Bijl L, de Wijn R, Hilhorst R, Ruijtenbeek R, Sabbah M, Kerger J, Awada A, Journe F, Ghanem G
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12

Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. <i>

Auteurs : Krayem M, Aftimos P, Najem A, Hooven TVD, Berg AVD, Hovestad-Bijl L, Wijn R, Hilhorst R, Ruijtenbeek R, Sabbah M, Kerger J, Awada A, Journe F, Ghanem G
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12

ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection.

Auteurs : Descamps G, Verset L, Trelcat A, Hopkins C, Lechien JR, Journe F, Saussez S
Jaar : 2020
Journal : Biology (Basel)
Volume : 9

Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.

Auteurs : Lechien JR, Seminerio I, Descamps G, Mat Q, Mouawad F, Hans S, Julieron M, Dequanter D, Vanderhaegen T, Journe F, Saussez S
Jaar : 2019
Journal : Cells
Volume : 8

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.

Auteurs : Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S, Sales F, Journe F, Awada A, Ghanem G, Van Gestel D
Jaar : 2019
Journal : Cancers (Basel)
Volume : 11

Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.

Auteurs : Kindt N, Descamps G, Lechien JR, Remmelink M, Colet JM, Wattiez R, Berchem G, Journe F, Saussez S
Jaar : 2019
Journal : J Clin Med
Volume : 8

Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis.

Auteurs : Lechien JR, Saussez S, Schindler A, Karkos PD, Hamdan AL, Harmegnies B, De Marrez LG, Finck C, Journe F, Paesmans M, Vaezi MF
Jaar : 2019
Journal : Laryngoscope
Volume : 129
Pagina's : 1174-1187

Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma.

Auteurs : Soumoy L, Kindt N, Ghanem G, Saussez S, Journe F
Jaar : 2019
Journal : Cancers (Basel)
Volume : 11

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma.

Auteurs : Krayem M, Najem A, Journe F, Morandini R, Sales F, Awada A, Ghanem G
Jaar : 2018
Journal : Oncotarget
Volume : 9
Pagina's : 31888-31903

High infiltration of CD68+ macrophages is associated with poor prognoses of head and neck squamous cell carcinoma patients and is influenced by human papillomavirus.

Auteurs : Seminerio I, Kindt N, Descamps G, Bellier J, Lechien JR, Mat Q, Pottier C, Journe F, Saussez S
Jaar : 2018
Journal : Oncotarget
Volume : 9
Pagina's : 11046-11059

New Drug Combination Strategies in Melanoma: Current Status and Future Directions.

Auteurs : Najem A, Krayem M, Perdrix A, Kerger J, Awada A, Journe F, Ghanem G
Jaar : 2017
Journal : Anticancer Res
Volume : 37
Pagina's : 5941-5953

MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.

Auteurs : Zhan Y, Guo J, Yang W, Goncalves C, Rzymski T, Dreas A, Mikulski M, Brzózka K, Golas A, Kong Y, Ma M, Huang F, Huor B, Guo Q, da Silva SD, Torres J, Cai Y, Topisirovic I, Su J, Bijian K, Alaoui-Jamali MA, Huang S, Journe F, Ghanem G, Miller WH Jr, Del Rincón SV
Jaar : 2017
Journal : J Clin Invest
Volume : 127
Pagina's : 4179-4192

Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer.

Auteurs : Arcolia V, Journe F, Renaud F, Leteurtre E, Gabius HJ, Remmelink M, Saussez S
Jaar : 2017
Journal : Oncol Lett
Volume : 14
Pagina's : 4183-4189

A non-coding function of TYRP1 mRNA promotes melanoma growth.

Auteurs : Gilot D, Migault M, Bachelot L, Journe F, Rogiers A, Donnou-Fournet E, Mogha A, Mouchet N, Pinel-Marie ML, Mari B, Montier T, Corre S, Gautron A, Rambow F, El Hajj P, Ben Jouira R, Tartare-Deckert S, Marine JC, Felden B, Ghanem G, Galibert MD
Jaar : 2017
Journal : Nat Cell Biol
Volume : 19(11)
Pagina's : 1348-1357

PRIMA-1 and PRIMA-1 Met(APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies.

Auteurs : Perdrix A, Najem A, Saussez S, Awada A, Journe F, Ghanem G, Krayem M
Jaar : 2017
Journal : Cancers (Basel)
Volume : 9

Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas.

Auteurs : Kindt N, Journe F, Ghanem G, Saussez S
Jaar : 2017
Journal : Int J Mol Sci
Volume : 18